STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Common Stock [Member] Class B Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Feb. 22, 2021	$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Feb. 22, 2021	0
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of Class B common stock to Sponsor	$ 575	24,425	0	25,000
Issuance of Class B common stock to Sponsor (in shares)	5,750,000
Sale of 23,000,000 Units through public offering	$ 0	229,997,700	0	229,997,700
Sale of 23,000,000 Units through public offering (in shares)	0
Sale of 11,200,000 Private Placement Warrants	$ 0	11,200,000	0	11,200,000
Net offering costs	0	(12,947,813)	0	(12,947,813)
Initial fair value of warrant liability	0	(16,571,000)	0	(16,571,000)
Excess of cash received over fair value of private placement warrants	0	3,024,000	(3,024,000)	0
Accretion for Class A common stock to redemption amount				(234,600,000)
Net income	0	0	3,829,169	3,829,169
Class A common stock subject to possible redemption		(214,727,312)	(19,870,388)	(234,597,700)
Ending balance at Dec. 31, 2021	$ 575	0	(19,065,219)	(19,064,644)
Ending balance (in shares) at Dec. 31, 2021	5,750,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net offering costs				(12,947,813)
Accretion for Class A common stock to redemption amount	$ 0	0	(2,420,680)	(2,420,680)
Net income	0	0	11,530,114	11,530,114
Ending balance at Dec. 31, 2022	$ 575	$ 0	$ (9,955,785)	$ (9,955,210)
Ending balance (in shares) at Dec. 31, 2022	5,750,000